DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells

By Martinez Osvaldo  

International Immunology, Vol. 17, Iss. 6, 2005-06 ,pp. : 769-778

Oxford University Press

Access to resources Recommend Favorite

Inhibition of Chronic Rejection After Kidney Transplantation by Anti-CD4 Treatment

By Risch K.   Becker G.   Graser E.   Nizze H.   Brock J.   Volk H.-D.   Heemann U.   Lehmann M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 328-329

Elsevier

Access to resources Recommend Favorite

Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance

By Nagahama Kanji   Fehervari Zoltan   Oida Takatoku   Yamaguchi Tomoyuki   Ogawa Osamu   Sakaguchi Shimon  

International Immunology, Vol. 21, Iss. 4, 2009-04 ,pp. : 379-391

Oxford University Press

Access to resources Recommend Favorite

CD4CD25FoxP3 regulatory T cells enhance the allogeneic activity of endothelial-specific CD8/CD28CTL

By Eissner Gnther   Hartmann Isabel   Kesikli Altug   Holler Ernst   Haffner Silvia   Sax Tanja   Schray Carolin   Meiser Bruno   Reichart Bruno  

International Immunology, Vol. 23, Iss. 8, 2011-08 ,pp. : 485-492

Oxford University Press

Access to resources Recommend Favorite

Effect of Long-Term Anti-CD4 or Anti-CD8 Treatment on the Development of lpr CD4 CD8 Double Negative T Cells and of the Autoimmune Syndrome in MRL- lpr / lpr Mice

By Merino R.   Fossati L.   Iwamo to M.   Takahashi S.   Lemoine R.   Ibnou-Zekri N.   Pugliatti L.   Merino J.   Izui S.  

Journal of Autoimmunity, Vol. 8, Iss. 1, 1995-01 ,pp. : 33-45

Academic Press

Access to resources Recommend Favorite